Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

Stock Analyst Downgrades

Explore the most recent stock downgrades, analyst downgrades, and changes to stock analyst ratings in this continuously updated list of analyst recommendations. This page captures each newly issued downgrade, including adjustments to stock ratings, price targets, and analyst coverage, making it easy to follow all the latest downgrades and rating changes.

On This Page:FAQ
Export
CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Acerinox stock logo
ANIOY
Acerinox
Downgraded by
BNP Paribas Exane logo
BNP Paribas Exane
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 $9.28
Neutral ➝ Underperform
Aperam stock logo
APEMY
Aperam
Downgraded by
BNP Paribas Exane logo
BNP Paribas Exane
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 $47.19
Neutral ➝ Underperform
BridgeBio Oncology Therapeutics, Inc stock logo
BBOT
BridgeBio Oncology Therapeutics
Downgraded by
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 $8.92
+7.6%		Overweight
Bath & Body Works, Inc. stock logo
BBWI
Bath & Body Works
Downgraded by
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Kate McShane
Kate McShane
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$19.43
-5.8%		$23.00 ➝ $19.00Neutral ➝ Sell
Community Health Systems, Inc. stock logo
CYH
Community Health Systems
Downgraded by
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Andrew Mok
Andrew Mok
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$3.60
-5.9%		$3.00Equal Weight ➝ Underweight
Dollar Tree, Inc. stock logo
DLTR
Dollar Tree
Downgraded by
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Kate McShane
Kate McShane
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$124.21
+1.3%		Neutral ➝ Sell
Globant S.A. stock logo
GLOB
Globant
Downgraded by
Itau BBA Securities logo
Itau BBA Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Maria Clara Infantozzi
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$30.04
-5.1%		$39.00Outperform ➝ Market Perform
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Downgraded by
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Andrew Mok
Andrew Mok
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$411.63
-2.7%		Overweight ➝ Negative
Rio Tinto PLC stock logo
RIO
Rio Tinto
Downgraded by
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 $88.70
-2.8%		Equal Weight ➝ Underweight
Sabra Healthcare REIT, Inc. stock logo
SBRA
Sabra Healthcare REIT
Downgraded by
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Michael Lewis
Michael Lewis
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$20.05
0.0%		Buy ➝ Hold
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
Downgraded by
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Andrew Mok
Andrew Mok
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
$156.28
-3.1%		Overweight ➝ Negative

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:07 PM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports  and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.


Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Top Stock Recommendations by Brokerage